网站主页 >> CAS数据库列表 >> (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
|
|
- CAS号:
- 4542-23-8
- 英文名:
- (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
- 英文别名:
- Succinoadenosine;Succinyladenosine;N6-Succinyl Adenosine;(S)-N-(1,2-Dicarboxyethyl)adenosine;N-<9-(β-ribofuranosyl)-9H-purin-6-yl>-L-aspartic acid;N-(9-β-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic Acid;6-(1,2-DicarboxyethylaMino)
-9-β-D-ribofuranosylpurine;L-Aspartic acid, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-;(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid;(S)-2-((9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)succinic acid
- 中文名:
- (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
- 中文别名:
- 琥珀酰腺苷;N6琥珀酰腺苷
- CBNumber:
- CB41236264
- 分子式:
- C14H17N5O8
- 分子量:
- 383.31
- MOL File:
- 4542-23-8.mol
|
|
|
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid化学性质
-
熔点:
-
>180°C (dec.)
-
|
-
沸点:
-
816.4±75.0 °C(Predicted)
-
|
-
密度:
-
2.02±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
-20°C Freezer
-
|
-
溶解度:
-
DMSO (Slightly), Methanol (Slightly, Heated)
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
3.52±0.23(Predicted)
-
|
-
颜色:
-
White to Off-White
-
|
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid性质、用途与生产工艺
Succinyladenosine,是胞内腺苷酸 (S-AMP) 经 5-核苷酸酶脱磷酸化的产物,是腺苷酸琥珀酸酶 (ASL) 缺乏的生化标志。
Human Endogenous Metabolite
|
The presence of high concentrations of Succinyladenosine (S-Ado) in the human cerebrospinal fluid (CSF) in the range of 100–500 μmol/L is a diagnostic marker for inherited enzyme deficiency of ASL.
用途
Succinyladenosine (S-Ado) is a biochemical marker of adenylosuccinase deficiency - the genetic defect of purine de novo synthesis.S-Ado has been previously reported as normally undetectable in cereb
rospinal fluid (CSF) of children not suffering from this defect.
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-113284 | (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid Succinyladenosine | 4542-23-8 | 1mg | 3900元 |
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid
生产厂家
4542-23-8, (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid 相关搜索:
- Nuc
- Pharmaceuticals
- Nucleotides
- Intermediates & Fine Chemicals
- Chiral Reagents
- Bases & Related Reagents
- 抑制剂
- 杂质对照品
- 核苷,核苷酸及寡核苷酸
- C14H17N5O8
- 琥珀酰腺苷
- N6琥珀酰腺苷
- 4542-23-8
- (S)-2-((9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)amino)succinic acid
- L-Aspartic acid, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-
- N-<9-(β-ribofuranosyl)-9H-purin-6-yl>-L-aspartic acid
- Succinoadenosine
- N-(9-β-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic Acid
- 6-(1,2-DicarboxyethylaMino)
-9-β-D-ribofuranosylpurine
- (S)-N-(1,2-Dicarboxyethyl)adenosine
- N6-Succinyl Adenosine
- Succinyladenosine
- (2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid